• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Cubist Pharmaceuticals - Articles and news items


Cubist announces continued global expansion with opening of International Headquarters in Zurich

Industry news / 18 September 2014 / Cubist Pharmaceuticals

With resistant bacterial infections resulting in an estimated 25,000 deaths in the European Union and 23,000 deaths in the United States annually, the issues of rising antibiotic resistance and the lack of treatment options have raised alarms with world leaders…


Cubist announces positive top-line results from phase 3 trial of investigational antibiotic ceftolozane/tazobactam…

Industry news / 25 November 2013 / Cubist

“We are very pleased with these positive results, which represent a significant milestone for both ceftolozane/tazobactam and Cubist…”


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +